Exact Mass: 344.21266160000005
Exact Mass Matches: 344.21266160000005
Found 500 metabolites which its exact mass value is equals to given mass value 344.21266160000005,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Medroxyprogesterone
Medroxyprogesterone, or MP is a progestin (synthetic progestogen). MP is not used medically, as it is over two orders of magnitude less potent than medroxyprogesterone acetate (MPA); a derivative of MP (PMID: 16784762). MP may be formed via the metabolism of MPA. Medroxyprogesterone acetate is used to treat conditions such as absent or irregular menstrual periods, or abnormal uterine bleeding. Synthetic progestogens are widely used to simulate the effects of progesterone; a natural female sex hormone. Progesterone is essential for endometrial receptivity, embryo implantation, and the successful establishment of pregnancy. A low progesterone concentration or an insufficient response to progesterone can cause infertility and pregnancy loss (PMID: 20104424). In addition to progestagenic activity, MP is also a weak antiandrogen in vitro (PMID: 29990947). Medroxyprogesterone is only found in individuals that have used or taken MPA. A synthetic progesterone (steroid hormone) involved in the female menstrual cycle, pregnancy (supports gestation) and embryogenesis of humans and other species. Progesterone belongs to a class of hormones called progestagens, and is the major naturally occurring human progestagen. -- Wikipedia G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03A - Hormonal contraceptives for systemic use > G03AC - Progestogens G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03D - Progestogens > G03DA - Pregnen (4) derivatives L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02A - Hormones and related agents > L02AB - Progestogens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents
Testosterone Propionate
Testosterone Propionate is only found in individuals that have used or taken this drug. It is an ester of testosterone with a propionate substitution at the 17-beta position. [PubChem]The effects of testosterone in humans and other vertebrates occur by way of two main mechanisms: by activation of the androgen receptor (directly or as DHT), and by conversion to estradiol and activation of certain estrogen receptors. Free testosterone (T) is transported into the cytoplasm of target tissue cells, where it can bind to the androgen receptor, or can be reduced to 5α-dihydrotestosterone (DHT) by the cytoplasmic enzyme 5α-reductase. DHT binds to the same androgen receptor even more strongly than T, so that its androgenic potency is about 2.5 times that of T. The T-receptor or DHT-receptor complex undergoes a structural change that allows it to move into the cell nucleus and bind directly to specific nucleotide sequences of the chromosomal DNA. The areas of binding are called hormone response elements (HREs), and influence transcriptional activity of certain genes, producing the androgen effects. C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Medrysone
Medrysone is only found in individuals that have used or taken this drug. It is a corticosteroid used in ophthalmology. [Wikipedia]There is no generally accepted explanation for the mechanism of action of ocular corticosteroids. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Initially, the drug binds to the glucocorticoid receptor in the cytosol. This migrates to the nucleus and binds to genetic elements which cause activation and repression of the involved genes in the inflammatory pathway. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BA - Corticosteroids, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid Same as: D02289
11-Dehydrocorticosterone
11-Dehydrocorticosterone is a mineral corticosteroid. The conversion of inactive 11-ketoglucocorticoids such as 11-dehydrocorticosterone) into active 11b-hydroxyglucocorticoids (such as corticosterone) is catalyzed by 11beta-hydroxysteroid dehydrogenase (11b-HSD1, EC 1.1.1.146), which is expressed in many tissues and plays an important role in metabolically relevant tissues such as the liver, adipose tissue, skeletal muscles and possibly kidney. Chronically elevated local glucocorticoid action as a result of increased 11beta-HSD1 activity rather than elevated systemic glucocorticoid levels has been associated with metabolic syndrome, which is characterized by obesity, insulin resistance, type 2 diabetes and cardiovascular complications. Recent studies indicate that compounds inhibiting 11beta-HSD1 activity ameliorate the adverse effects of excessive glucocorticoid concentrations on metabolic processes, providing promising opportunities for the development of therapeutic interventions. 11-dehydrocorticosterone and corticosterone display antinatriuretic activity, although 11-dehydrocorticosterone is generally a more potent sodium retainer than corticosterone. (PMID: 17584152, Endocr Metab Immune Disord Drug Targets. 2007 Jun;7(2):125-40.) [HMDB] 11-Dehydrocorticosterone is a mineral corticosteroid. The conversion of inactive 11-ketoglucocorticoids such as 11-dehydrocorticosterone) into active 11b-hydroxyglucocorticoids (such as corticosterone) is catalyzed by 11beta-hydroxysteroid dehydrogenase (11b-HSD1, EC 1.1.1.146), which is expressed in many tissues and plays an important role in metabolically relevant tissues such as the liver, adipose tissue, skeletal muscles and possibly kidney. Chronically elevated local glucocorticoid action as a result of increased 11beta-HSD1 activity rather than elevated systemic glucocorticoid levels has been associated with metabolic syndrome, which is characterized by obesity, insulin resistance, type 2 diabetes and cardiovascular complications. Recent studies indicate that compounds inhibiting 11beta-HSD1 activity ameliorate the adverse effects of excessive glucocorticoid concentrations on metabolic processes, providing promising opportunities for the development of therapeutic interventions. 11-dehydrocorticosterone and corticosterone display antinatriuretic activity, although 11-dehydrocorticosterone is generally a more potent sodium retainer than corticosterone. (PMID: 17584152, Endocr Metab Immune Disord Drug Targets. 2007 Jun;7(2):125-40.).
Oxyphencyclimine
C20H28N2O3 (344.20998180000004)
Oxyphencyclimine is only found in individuals that have used or taken this drug. It is an anticholinergic drug (trade name Daricon) used in treating peptic ulcers.Oxyphencyclimine binds the muscarinic acetylcholine receptor. It may block all three types of muscarinic receptors including M-1 receptors in the CNS and ganglia, M-2 receptors in the heart (vagus) and M-3 receptors at the parasympathetic NEJ system. The muscarinic acetylcholine receptors mediate various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Oxphencyclimine inhibits vagally mediated reflexes by antagonizing the action of acetylcholine. This in turn reduces the secretion of gastric acids in the stomach. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AA - Synthetic anticholinergics, esters with tertiary amino group C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent
Lamtidine
C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist
16-Propyl-3-methoxy-estra-1,3,5(10)-triene-16beta,17beta-diol
17-hydroxy-17-methylandrosta-4,6-dien-3-yl acetate
(4Z,7Z,10Z,13Z,16Z,19Z)-22-Hydroxydocosahexaenoic acid
A HDoHE obtained by hydroxylation at position 2 of all-cis-docosa-4,7,10,13,16,19-hexaenoic acid.
Methenolone Acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid
20-HDoHE
20-HDoHE is an autoxidation product of docosahexaenoic acid DHA. 20-HDoHE is a long-chain polyunsaturated fatty acid that is any docosahexaenoic acid bearing a single hydroxy substituent. An oxidation product of docosahexaenoic acid metabolism. (CHEBI:72790)
7-HDoHE
7-HDoHE is an autoxidation product of docosahexaenoic acid DHA. 7-HDoHE is a long-chain polyunsaturated fatty acid that is any docosahexaenoic acid bearing a single hydroxy substituent. An oxidation product of docosahexaenoic acid metabolism. (CHEBI:72790)
8-HDoHE
8-HDoHE is an autoxidation product of docosahexaenoic acid DHA. 8-HDoHE is a long-chain polyunsaturated fatty acid that is any docosahexaenoic acid bearing a single hydroxy substituent. An oxidation product of docosahexaenoic acid metabolism. (CHEBI:72790)
16-HDoHE
16-HDoHE is an autoxidation product of docosahexaenoic acid DHA. 16-HDoHE is a long-chain polyunsaturated fatty acid that is any docosahexaenoic acid bearing a single hydroxy substituent. An oxidation product of docosahexaenoic acid metabolism. (CHEBI:72790)
11-HDoHE
11-HDoHE is an autoxidation product of docosahexaenoic acid DHA. 11-HDoHE is a long-chain polyunsaturated fatty acid that is any docosahexaenoic acid bearing a single hydroxy substituent. An oxidation product of docosahexaenoic acid metabolism. (CHEBI:72790)
10-HDoHE
10-HDoHE is an autoxidation product of docosahexaenoic acid (DHA) in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes. (±)10-HDoHE is a potential marker of oxidative stress in brain and retina where DHA is an abundant polyunsaturated fatty acid. (http://bioreagent.bertinpharma.com)
11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol
11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol, also known as delta(1)-Tetrahydrocannabinol-7-Oic acid or delta-9-11-Carboxytetrahydrocannabinol, is classified as a member of the 2,2-dimethyl-1-benzopyrans. 2,2-dimethyl-1-benzopyrans are organic compounds containing a 1-benzopyran moiety that carries two methyl groups at the 2-position. 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol is considered to be practically insoluble (in water) and acidic
3-Hydroxyneogrifolin
3-Hydroxyneogrifolin is found in mushrooms. 3-Hydroxyneogrifolin is a constituent of Albatrellus ovinus. Constituent of Albatrellus ovinus. 3-Hydroxyneogrifolin is found in mushrooms.
(E,E)-Boviquinone 3
(E,E)-Boviquinone 3 is found in mushrooms. (E,E)-Boviquinone 3 is a pigment from Chroogomphus rutilus (pine spike cap Pigment from Chroogomphus rutilus (pine spike cap). (E,E)-Boviquinone 3 is found in mushrooms.
Neotussilagolactone
Neotussilagolactone is found in tea. Neotussilagolactone is a constituent of Tussilago farfara (coltsfoot) Constituent of Tussilago farfara (coltsfoot). Neotussilagolactone is found in tea.
Anacardic acid
Anacardic acid is found in cashew nut. Anacardic acid is found in cashew nut shell.Anacardic acids are chemical compounds found in the shell of the cashew nut (Anacardium occidentale). Chemically, anacardic acid is a mixture of several closely related organic compounds. Each consists of a salicylic acid substituted with an alkyl chain that has 15 or 17 carbon atoms; anacardic acid is a mixture of saturated and unsaturated molecules. The exact mixture depends on the species of the plant and the major component is C5:3 all-Z. (Wikipedia Found in cashew nut shell
19(20)-EpDPE
19(20)-EpDPE is a DHA epoxygenase metabolite, derived via epoxidation of the w-3 double bond of DHA. The EDHF (endothelium-derived hyperpolarizing factor) activity of 19(20)-EpDPE has not yet been determined. The epoxygenase metabolites of DHA have also been detected in a murine inflammation model (PMID: 12391014). EDHF is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators (PMID: 9504399, 10519554). Cytochrome P450 (CYP450) metabolism of polyunsaturated fatty acids produces epoxides such as 14(15)-EpETrE which are prime candidates for the actual active mediator (PMID: 9401962). However, the CYP450 metabolites of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been little studied relative to arachidonate epoxygenase metabolites. 19(20)-EpDPE is a DHA epoxygenase metabolite, derived via epoxidation of the w-3 double bond of DHA. The EDHF activity of 19(20)-EpDPE has not yet been determined. The epoxygenase metabolites of DHA have also been detected in a murine inflammation model
16(17)-EpDPE
16(17)-EpETE is the DHA homolog of 14(15)-EpETrE, derived via epoxidation of the 16,17-double bond of docosahexaenoic acid (DHA). The EDHF (endothelium-derived hyperpolarizing factor) activity of 16(17)-EpDPE has not yet been determined. The epoxygenase metabolites of DHA have also been detected in a murine inflammation model (PMID: 12391014). EDHF is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators (PMID: 9504399, 10519554). Cytochrome P450 (CYP450) metabolism of polyunsaturated fatty acids produces epoxides such as 14(15)-EpETrE which are prime candidates for the actual active mediator (PMID: 9401962). However, the CYP450 metabolites of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been little studied relative to arachidonate epoxygenase metabolites. EDHF (endothelium-derived hyperpolarizing factor) is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators.1,2 Cytochrome P450 (CYP450) metabolism of polyunsaturated fatty acids produces epoxides such as 14(15)-EpETrE which are prime candidates for the actual active mediator.3 However, the CYP450 metabolites of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been little studied relative to arachidonate epoxygenase metabolites. 16(17)-EpETE is the DHA homolog of 14(15)-EpETrE, derived via epoxidation of the 16,17-double bond of docosahexaenoic acid (DHA). The EDHF activity of 16(17)-EpDPE has not yet been determined. The epoxygenase metabolites of DHA have also been detected in a murine inflammation model [HMDB]
Formebolone
Formebolone is a synthetic anabolic steroid. It is suspected of misuse in sports and therefore tested for in regular screening of athletes. The desire to artificially enhance physical performance in order to increase the chances to win in sports competition is supposedly as old as mankind itself. Already during the ancient Olympic Games, in approximately 200 B.C., athletes used concoctions of mushrooms and plant seeds, as well as special diets including bovine and canine testicles, as reported by Philostratos and Galen. The attempt to improve the power and strength of racing animals also has a long history, as it has been reported that the ancient Romans fed their horses so-called Hydromel, a mixture of honey and water, in order to increase endurance. The manipulation of the capacities of an athlete or animal has been referred to as doping since 1889, when this term, originating from a dialect spoken in the south-eastern region of Africa, was included in a British dictionary. With the athlete Linton, the first authentic doping-related death occurred in 1886 during a cycle race (Paris-Bordeaux), caused by an overdose of caffeine. (For a more complete review on doping see PMID: 15808003) [HMDB] Formebolone is a synthetic anabolic steroid. It is suspected of misuse in sports and therefore tested for in regular screening of athletes. The desire to artificially enhance physical performance in order to increase the chances to win in sports competition is supposedly as old as mankind itself. Already during the ancient Olympic Games, in approximately 200 B.C., athletes used concoctions of mushrooms and plant seeds, as well as special diets including bovine and canine testicles, as reported by Philostratos and Galen. The attempt to improve the power and strength of racing animals also has a long history, as it has been reported that the ancient Romans fed their horses so-called Hydromel, a mixture of honey and water, in order to increase endurance. The manipulation of the capacities of an athlete or animal has been referred to as doping since 1889, when this term, originating from a dialect spoken in the south-eastern region of Africa, was included in a British dictionary. With the athlete Linton, the first authentic doping-related death occurred in 1886 during a cycle race (Paris-Bordeaux), caused by an overdose of caffeine. (For a more complete review on doping see PMID: 15808003). C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid
19-Oxo-deoxycorticosterone
19-oxo-deoxycorticosterone (19-oxo-DOC) is a steroid recently isolated from the rat adrenal gland.19-Oxo-Deoxycorticosterone Binds to the Renal Mineralocorticoid Receptor and Produces Sodium Retention but Not Potassium Excretion.19-oxo-DOC both binds to type I renal mineralocor-ticoid receptors and produces the expected antinatriuretic effect of maximal doses of mineralocorticoids. This lack of a kaliuretic effect suggests that either 1) the kaliuretic effect of steroids such as aldosterone is mediated by a binding site other than the type I receptors, or 2) that potassium secretion mediated by aldoster-one-type I receptor interactions in discrete nephron target segments can be influenced by a steroid-sensitive potassium-recycling system in a more distal nephron site. 19-hydroxydeoxycorticosterone (19,21-dihydroxy-4-pregnen-3,20-dione), 19-oxo-deoxycorticosterone (21-hydroxy-4-pregnen-3,19,20-trione), and 19-oic-deoxycorticosterone (19-oic-21-hydroxy-4-pregnen-3,20-dione)are formed from precursor deoxycorticosterone by adrenal glands obtained from intact rats and from rats undergoing adrenal regeneration.rat adrenals have the enzymes required to convert deoxycorticosterone to 19-hydroxydeoxycorticosterone, 19-oxo-deoxycorticosterone, and 19-oic-deoxycorticosterone; however, rat adrenals do not convert deoxycorticosterone or any of the oxygenated metabolites to 19-nor-deoxycorticosterone (21-hydroxy-19-nor-4-pregnen-3,20-dione). It is possible, however, that 19-nor-deoxycorticosterone is formed at peripheral sites from the oxygenated deoxycorticosterone precursors. 19-oxo-deoxycorticosterone (19-oxo-DOC) is a steroid recently isolated from the rat adrenal gland.19-Oxo-Deoxycorticosterone Binds to the Renal Mineralocorticoid Receptor and Produces Sodium Retention but Not Potassium Excretion.19-oxo-DOC both binds to type I renal mineralocor-ticoid receptors and produces the expected antinatriuretic effect of maximal doses of mineralocorticoids. This lack of a kaliuretic effect suggests that either 1) the kaliuretic effect of steroids such as aldosterone is mediated by a binding site other than the type I receptors, or 2) that potassium secretion mediated by aldoster-one-type I receptor interactions in discrete nephron target segments can be influenced by a steroid-sensitive potassium-recycling system in a more distal nephron site
4-Hydroxy-all-trans-retinyl acetate
This compound belongs to the family of Retinoids. These are compounds that is related to vitamin A, especially retinol.
(6Ar,10ar)-1-hydroxy-6,6-dimethyl-3-pentyl-6a,7,10,10a-tetrahydro-6h-benzo[c]chromene-9-carboxylic acid
7-Oxodehydroepiandrosterone 3-acetate
21-Deoxycortisone
4-Acetoxy-4-androstene-3,17-dione
methoxyprogesterone
[(8S,9S,13S,14S,17R)-3,17-Dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-1-yl] propanoate
(8R,9S,10R,13S,14S,16R,17S)-16-Ethyl-17-(2-hydroxyacetyl)-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one
15,16-Epoxy-20-oxo-8(17),13(16),14-labdatrien-19-oic acid methyl ester
[4S-[4alpha(E),4aalpha,5alpha,8abeta]]-4,4a,5,6,7,8,8a,9-Octahydro-3,4a,5-trimethyl-9-oxonaphtho[2,3-b]furan-4-yl ester 3-methyl-2-pentenoic acid
12-Methyl-5-dehydrohorminone
An abietane diterpenoid that is 5-dehydrohorminone in which the hydroxy group at position 12 is replaced by a methoxy group. Isolated from the roots of Salvia multicaulis, it exhibits antitubercular activity.
6,12-dihydroxy-11-methoxyabieta-5,8,11,13-tetraen-7-one
3beta-acetoxy-12-methoxy-13-methyl-podocarpa-8,11,13-trien-7-one|3beta-acetoxy-12-methoxy-13-methyl-podocarpane-8,11,13-trien-7-one|3beta-acetoxy-12-methoxy-13-methylpodocarpa-8,11,13-trien-7-one|3??-Acetoxy-12-methoxy-13-methyl-podocarpa-8,11,13-trien-7-one.
(4R,9R)-10-hydroxy-13-methoxy-9-methyl-15-oxo-20-norkaur-16-en-18-oic acid gamma-lactone
(1R*,3E,7E,9S*,11S*)-9-acetoxydolabella-3,7,12-trien-16-al
2,11beta-Dimethoxy-3-hydoxo-D-homoestra-1,3,5(10)trien-17a-on
2-(4,8-dimethylnona-3,7-dienyl)-3,4-dihydro-2,7-dimethyl-2H-[1]benzopyran-3,5-diol
3beta-acetoxy-8,11,13-abietatrien-12-ol|3beta-acetoxyabieta-8,11,13-trien-12-ol
(2E)-1,4-diacetoxy-2-(3,7-dimethylocta-2,6-dienyl)-6-methylbenzene
6beta-hydroxy-3beta-<4-methylsenecioyloxy>-euryopsin
19-Acetoxy-12,17-epoxy-14alpha-methyl-15-nor-pimara-12,16-dien|19-acetoxy-12,17-epoxy-14alpha-methyl-15-nor-pimara-12,16-diene
Methyl 15,16-epoxy-12-oxo-8(17),13(16),14-ent-labdatrien-19-oate
12-O-acetyl-18-hydroxyferruginol|O-Acetyl-18-hydroxyferruginol
bacchalineol acetate|bacchalineol-18-acetate|Hardwickiolacetat
15-desmethoxy-16-oxo-15,16H-seco-nidoresedic acid methyl ester|15-desmethoxy-16-oxo-15,16H-strictic acid methyl ester|methyl ester of 16-oxo-15,16H-strictic acid
10,11-dimethoxy-17-nor-corynan-16-ol|Ochropposinin
C20H28N2O3 (344.20998180000004)
5alpha-Hydroxyconyscabrasaeure-methylester|methyl 5alpha-hydroxyconyscabroate
5-methyl-2-[(2E,7Z)-3,7,11-trimethyl-2,7-dodecadien-9-onyl]-1,4-dihydroxybenzene
4beta-hydroxy-5beta,6beta-epoxypregn-2-ene-1,20-dione
(6aR,8R,9aR)-8-methoxy-6a-methyl-8-pentyl-3-((E)-prop-1-enyl)-6a,8,9,9atetrahydro-6H-furo[2,3-h]-isochromen-6-one|monapurone C
18-Acetoxy-3,13(16),14-clerodatrien-2-one|2-oxo-18-acetoxy-10alpha,17alpha,19alpha,20beta-(-)-cleroda-3,13(16),14-triene
5-methyl-2-[(2E,6E)-3,7,11-trimethyl-2,6-dodecadien-9-onyl]-1,4-dihydroxybenzene
6-alpha-acetoxyvouacapane|6alpha-Acetoxyvouacapane
12-methylcoleon U|6,11-dihydro-12-methoxy-5,8,11,13-abietatetraen-7-one
16-methoxy-6-oxo-7,11,13-labdatrien-16,15-olide|spicatanol methyl ether
5alpha-hydroxy-1,2-dehydro-5,10-dihydroprintzianic acid methyl ester|5alpha-Hydroxy-1,2-dehydro-5,10-dihydroprintziasaeure-methylester
4a.alpha.,4b.beta.-Gibbane-1.alpha.,10.beta.-dicarboxylic acid, 4a-(hydroxymethyl)-1-methyl-8-methylene-, 1,4a-lactone, methyl ester
7(R*)-acetoxy-13-keto-(1S*,11R*)-dolabella-3(E),8(17),12(18)-triene|Ac-7-Hydroxy-3,8(17),12(18)-dolabellatrien-13-one
(4S*,14S*)-4-acetoxy-14-hydroxydolasta-1(15),7,9-triene|4(SR)-acetoxy-14(SR)-hydroxydolast-1(15),7,9-triene
8beta-hydroxy-14(17)-ene-18alpha-methoxycarbonyl-18-norvouacapene|mimosol A
15-oxo-14,16H-seco-nidoresedic acid methyl ester|15-oxo-14,16H-strictic acid methyl ester
3(R)-acetoxy-1(S),11(R),12(S)-dolabell-4(E),8(E),18-trien-16-al
(-)-(4S,5S,10R,20R)-12,18-dihydroxyabieta-8,11,13-trien-20-aldehyde 18,20-ethyl acetal
An abietane diterpenoid isolated from the stem bark of Fraxinus sieboldiana.
2-methyl-2-((3E)-4,8-dimethylnona-37-dienyl)-3,4-dihydro-2H-1-benzopyran-8-methoxy-6-ol
methyl 14beta-hydroxy-12-oxo-3,4-secopimara-7,9(11),13,15,19(4)-tetraen-3-oate|trigonoheterene
(1R,3E,7E,11S,12S)-17-acetoxy-14-oxo-3,7,18-dolabellatriene
(1R,3E,6R,7E,11S,12S)-6-acetoxy-14-oxo-3,7,18-dolabellatriene
Sporidesmolinsaeure B|Sporidesmolsaeure|Sporidesmolsaeure B|Sporidesmolsaeure, L-alpha-Hydroxy-isovaleryl-L-valyl-N-methyl-L-leucin
C17H32N2O5 (344.23111020000005)
7beta-methoxy-8,11,13-triene-18,6alpha-abietanolide|liquidambolide A
(1R,3E,5R,7E,11S,12S)-5-acetoxy-14-oxo-3,7,18-dolabellatriene
17-oxo-3,4-seco-9betaH?17-octanorlanost-4(28),7-dien-3-oic acid|seco-coccinic acid H
(1R,3E,7S,11S,12S)-7-acetoxy-14-oxo-3,8(17),18-dolabellatriene
15beta,17alpha-dihydroxypregna-4,6-diene-3,20-dione
3alpha,4alpha-epoxy-5alpha-acetoxysphenoloba-13Z,16E,18-triene
4-O-[6,7-dihydro-5,6E-dehydro-7(9)-dehydrogeranyl]-sinapyl alcohol
15,16-epoxy-ent-labda-8(17),13(16),14-trien-19-ol acetate
Me ether-(9beta,10alpha,16alpha)-16-Hydroxypregn-4-ene-3,20-dione
4-O-geranyl-sinapyl aldehyde|4-O-geranylsinapyl aldehyde|geranyloxy sinapyl aldehyde|Nelumal A
5-methoxy-11.14-dioxo-abiata-8,12,15-triene|bractealine
13-dehydroxysarcoglaucol-16-one|2,5,6,9,10,13,14,16-octahydro-4,12,15-trimethyl-16-oxocyclotetradeca[b]furan-8-carboxylic acid methyl ester
Triptonoditerpenic acid
(E,E)-1,11-bis(furan-3-yl)-4,8-dimethylundeca-7,10-diene-4,6-diol|Untenospongin A
Ala Ala Ala Ile
Ala Ala Ala Leu
Ala Ala Ile Ala
Ala Ala Leu Ala
Ala Gly Val Val
Ala Ile Ala Ala
Ala Leu Ala Ala
Ala Val Gly Val
Ala Val Val Gly
Gly Ala Val Val
Gly Gly Ile Val
Gly Gly Leu Val
Gly Gly Val Ile
Gly Gly Val Leu
Gly Ile Gly Val
Gly Ile Val Gly
Gly Leu Gly Val
Gly Leu Val Gly
Gly Val Ala Val
Gly Val Gly Ile
Gly Val Gly Leu
Gly Val Ile Gly
Gly Val Leu Gly
Gly Val Val Ala
Ile Ala Ala Ala
Ile Gly Gly Val
Ile Gly Val Gly
Ile Val Gly Gly
Leu Ala Ala Ala
Leu Gly Gly Val
Leu Gly Val Gly
Leu Val Gly Gly
Val Ala Gly Val
Val Ala Val Gly
Val Gly Ala Val
Val Gly Gly Ile
Val Gly Gly Leu
Val Gly Ile Gly
Val Gly Leu Gly
Val Gly Val Ala
Val Ile Gly Gly
Val Leu Gly Gly
Val Val Ala Gly
Val Val Gly Ala
4-[4-(3,4-Dimethoxyphenyl)-2,3-dimethylbutyl]-2-methoxyphenol
11-DEHYDROCORTICOSTERONE
An 11-oxo steroid that is corticosterone in which the hydroxy substituent at the 11beta position has been oxidised to give the corresponding ketone. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Methyl α-Linolenyl Fluorophosphonate
Methyl γ-Linolenyl Fluorophosphonate
(E,E)-Boviquinone 3
Neotussilagolactone
FA 18:2;O4
ascr#19
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,11R)-11-hydroxydodec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
oscr#19
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-12-hydroxydodec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
Formebolone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid
ST 21:4;O4
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
[1-{[(2-Methyl-2-propanyl)oxy]carbonyl}-5-(1-piperidinyl)-1H-indo l-2-yl]boronic acid
C18H25BN2O4 (344.19072800000004)
tert-butyl 9-benzyl-10-oxo-1,9-diazaspiro[4.5]decane-1-carboxylate
C20H28N2O3 (344.20998180000004)
4-tert-butoxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester
2,2-dimethyl-1-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridin-1-yl]propan-1-one
tert-butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-b]pyridine-1-carboxylate
C18H25BN2O4 (344.19072800000004)
tert-butyl 4-(3-ethyl-2-oxo-3H-indol-1-yl)piperidine-1-carboxylate
C20H28N2O3 (344.20998180000004)
L-LYSYL-D-PROLYL-L-THREONINE
Lys-D-Pro-Thr, an IL-1beta analogue, is a potent IL-1 inhibitor. Lys-D-Pro-Thr inhibits the protective effects of IL-1 beta[1][2].
2-Methyl-2-propanyl 2-benzyl-3-oxo-2,8-diazaspiro[4.5]decane-8-ca rboxylate
C20H28N2O3 (344.20998180000004)
1-Boc-indazole-5-boronic acid pinacol ester
C18H25BN2O4 (344.19072800000004)
1-boc-4-[(2-cyano-ethyl)-pyridin-3-ylmethyl-amino]-piperidine
(S)-1,4-Di-tert-butyl 2-methyl piperazine-1,2,4-tricarboxylate
(R)-1,4-di-Boc-piperazine-2-carboxylic acid Methyl ester
1-(4-methyl-1-piperazinyl)-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-Ethanone
Thiourea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclopentyl-N-(2-methylpropyl)- (9CI)
Thiourea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclohexyl-N-propyl- (9CI)
tert-butyl 3-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate
C18H25BN2O4 (344.19072800000004)
1-[(1R,2R)-2-{[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]methyl}cyclohexyl]methanamine
N-HEXADECYLSULFURIC ACID SODIUM SALT
C16H33NaO4S (344.19971380000004)
1,4-DI-TERT-BUTYL 2-METHYL PIPERAZINE-1,2,4-TRICARBOXYLATE
Anecortave
S - Sensory organs > S01 - Ophthalmologicals > S01L - Ocular vascular disorder agents > S01LA - Antineovascularisation agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D006133 - Growth Substances > D006131 - Growth Inhibitors
Triptobenzene H
An abietane diterpenoid with formula C21H28O4, originally isolated from Tripterygium wilfordii.
(2E,11R)-11-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]dodec-2-enoic acid
(2E)-12-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]dodec-2-enoic acid
Estradiol 3-(trimethylsilyl) ether
C21H32O2Si (344.21714519999995)
N-(4-Carbamimidoylbenzyl)-1-(4-Methylpentanoyl)-L-Prolinamide
[(8S,9S,13S,14S,17R)-3,17-Dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-1-yl] propanoate
[3-carboxy-2-[(E)-9-carboxynon-6-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-9-carboxynon-5-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-9-carboxynon-2-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-9-carboxynon-7-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-9-carboxynon-4-enoyl]oxypropyl]-trimethylazanium
4-[(2S,3R)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-2-methoxyphenol
19-Oxo-deoxycorticosterone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Cyclohexanecarboxylic acid [2-oxo-2-[4-(1-piperidinyl)anilino]ethyl] ester
C20H28N2O3 (344.20998180000004)
(6aR)-1-hydroxy-6,6-dimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c][1]benzopyran-9-carboxylic acid
Diethyl (3-ethyl-1-ethoxy-2-oxoheptyl)propanedioate
6-De(cyclopropylamino)-6-(3-isopropoxyazetidin-1-yl)abacavir
C17H24N6O2 (344.19606439999995)
oxyphencyclimine
C20H28N2O3 (344.20998180000004)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AA - Synthetic anticholinergics, esters with tertiary amino group C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent
11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol
A phytocannabinoid that is Delta(9)-tetrahydrocannabinol in which the C-11 methyl has been fully oxidised to a carboxy group. Further enzymatic oxidation product of 11-hydroxy-Delta(9)-tetrahydrocannabinol.
21-deoxycortisone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
(E)-8-(5-(1,4-dihydroxyhex-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)octanoic acid
(E)-12-(5-ethyl-4-hydroxytetrahydrofuran-2-yl)-9,12-dihydroxydodec-10-enoic acid
(E)-9-hydroxy-11-(3-hydroxy-5-(1-hydroxypropyl)tetrahydrofuran-2-yl)undec-10-enoic acid
(E)-9-hydroxy-9-(4-hydroxy-5-(3-hydroxypent-1-en-1-yl)tetrahydrofuran-2-yl)nonanoic acid
(-)-(8R,8S)-3,3,4-trimethoxy-4-hydroxylignan
A lignan that is 2,3-dimethylbutane substituted by a 4-hydroxy-3-methoxyphenyl group at position 1 and a 3,4-dimethoxyphenyl group at position 4. It has been isolated from the bark of Machilus robusta.